All Press Releases for March 10, 2023

George Robert Painter III, PhD, Presented with the Albert Nelson Marquis Lifetime Achievement Award by Marquis Who's Who

Dr. George Robert Painter III, PhD, has been endorsed by Marquis Who's Who as a leader in drug development and higher education

The professorship recognized his contributions to developing a critical lifesaving antiviral drug that has since been approved globally for treating COVID-19.

    OVIEDO, FL, March 10, 2023 /24-7PressRelease/ -- Marquis Who's Who, the world's premier publisher of biographical profiles, is proud to present George Robert Painter III, PhD, with the Albert Nelson Marquis Lifetime Achievement Award. An accomplished listee, Dr. Painter celebrates many years' experience in his professional network, and has been noted for achievements, leadership qualities, and the credentials and successes he has accrued in his field. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.

For more than a decade, Dr. Painter has been a faculty member at Emory University in Atlanta, serving as the director of the Emory Institute for Drug Development (EIDD) and the Emory Institute for Drug Development and as the chief executive officer of Drug Innovation Ventures at Emory (DRIVE). He also teaches as a professor of pharmacology on campus.

As a seasoned scientist and leader of drug development, Dr. Painter became recognized as the director of chemistry and virology at Burroughs Wellcome Company beginning in 1983 and as the director of the research process and the international deputy therapeutic head of antiviral research at GlaxoSmithKline. Additionally, Dr. Painter established two biotechnology companies, Triangle Pharmaceuticals as the executive vice president of research and development and founding management team member and Connerix Inc. as the founder and chief executive officer.

Renowned for his contributions, Dr. Painter was responsible for discovering and developing the anti-human immunodeficiency virus drug, Emtricitabine (trade name Emtriva), during his tenure at GlaxoSmith Kline. The drug was designed to prevent and treat the human immunodeficiency virus (HIV) in adults and children. Emory University also recognized Dr. Painter by establishing an endowed distinguished professorship, the Endowed George R Painter III Distinguished Professor, in his honor. The professorship recognized his contributions to developing a critical lifesaving antiviral drug that has since been approved globally for treating COVID-19. Among other accomplishments, Dr. Painter co-invented and secured more than 150 U.S. patents, several of which have led to the approval of drugs or combinations of drugs that have become available to the public for the treatment of hepatitis B, smallpox, influenza, and other conditions. Dr. Painter has notably disseminated his findings by authoring more than 120 peer-reviewed articles.

Looking toward the future, Dr. Painter aims to pursue the next significant virus. He also plans to remain steadfast in establishing medicines and treatments to meet the needs of underserved populations. Moreover, Dr. Painter is considering launching another biotechnology company.

A graduate of Emory University, Dr. Painter received a Bachelor of Science in chemistry, a Master of Science in physical organic chemistry, and a Doctor of Philosophy in organic chemistry. He also served as a postdoctoral fellow at the California Institute of Technology.

To remain aware of developments in his field, Dr. Painter is a professional member of the International Society for Anti-Viral Research, the American Society of Microbiology, and the American Chemical Society. In recognition of his distinguished tenure in drug development, Dr. Painter has been recognized with a feature article in Atlanta Magazine.

About Marquis Who's Who®:
Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America®, Marquis Who's Who® has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Marquis celebrates its 125th anniversary in 2023, and Who's Who in America® remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. Marquis® publications may be visited at the official Marquis Who's Who® website at

# # #

Contact Information

-- --
Marquis Who's Who Ventures LLC
Uniondale, NY
Voice: 844-394-6946
E-Mail: Email Us Here
Website: Visit Our Website
Follow Us: